NEUREGULIN AND USE THEREOF

CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELL THAT TARGETS EGFR

Cell cultivation processes for preparing food products, products provided by said processes and a system for providing these processes

RECOMBINANT PRODUCTION OF GROWTH FACTORS IN ALGAE FOR CELL CULTURE APPLICATIONS

Silk Gland Recombinant Expression Vector of Silkworm (Bombyx Mori) Expressing Human Epidermal Growth Factor, Preparation Method and Use Thereof

RECOMBINANT HUMAN SERUM ALBUMIN-COLLAGEN BINDING DOMAIN FUSION PROTEIN FOR TUMOR-SPECIFIC TARGETING MATRIX, AND USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING INFECTIOUS DISEASES

RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES

Saccharomyces Cerevisiae Lysate Containing One or More Cytokines, Preparation Method Therefor and Application Thereof in Cell-Cultured Meat

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH USING NANOCAPSULE-BASED DRUG DELIVERY SYSTEM

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

RECOMBINANT ADENO-ASSOCIATED VIRUS PRODUCTS AND METHODS FOR TREATING DYSTROGLYCANOPATHIES AND LAMININ-DEFICIENT MUSCULAR DYSTROPHIES

PLANT-BASED SYNTHESIS PRODUCTS

METHOD FOR EXPRESSING AND PURIFYING PROTEIN BY USING CSQ-TAG

BACTERIA ENGINEERED TO SECRETE ACTIVE PROTEINS

SYNTHETIC INTERMEMBRANE PROTEOLYSIS RECEPTORS FOR CUSTOM ANTIGEN-INDUCED TRANSCRIPTIONAL REGULATION

ONCOLYTIC VIROTHERAPY WITH INDUCED ANTI-TUMOR IMMUNITY

PLANT-BASED SYNTHESIS PRODUCTS

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF CYTOPLASMIC AND CYTOSKELETAL PROTEINS

PHOSPHATIDYLSERINE BINDING AGENTS FOR THE DETECTION AND DEPLETION OF PHOSPHATIDYLSERINE POSITIVE CELLS

Bi-Specific Fusion Proteins

Bi-Specific Fusion Proteins

CELLULOSE BINDING DOMAIN (CBD) CELL EFFECTOR PROTEIN (CEP) CHIMERA, FOR THE TISSUE ENGINEERING

THERAPEUTIC FUSION PROTEINS

IMMUNOREGULATORY METHOD, NUCLEIC ACID COMPOSITION FOR IMMUNOREGULATION AND USE THEREOF

BIVALENT EGF FUSION TOXINS

METHODS AND USES FOR PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) INHIBITORS

SELF-ASSEMBLING SYNTHETIC PROTEINS

NOVEL HUMAN EPIDERMAL GROWTH FACTOR-TF FUSION PROTEIN AND USE THEREOF

PRODUCTION METHOD FOR ORGANOID

ENGINEERED NRG-1 VARIANTS WITH IMPROVED SELECTIVITY TOWARD ErbB4 BUT NOT AGAINST ErbB3

COMBINATION GRAFTS FOR TISSUE REPAIR OR REGENERATION APPLICATIONS

METHOD FOR EXPRESSING AND PURIFYING PROTEIN BY USING CSQ-TAG

TREATMENT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS

COMPOSITIONS AND METHODS FOR TREATMENT OF DISTENTABLE TISSUES

CHIMERIC ACTIVATORS: QUANTITATIVELY DESIGNED PROTEIN THERAPEUTICS AND USES THEREOF

Fusion protein comprising growth differentiation factor 11 and epidermal growth factor with enhanced anti-oxidation activity and enhanced skin cell proliferation effect and cosmetic composition for anti-wrinkle comprising the same as effective component

Recombinant proteins and their therapeutic uses

COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES

Bifunctional compounds comprising insulin peptides and EGF(A) peptides

EGFR blocking agents for the therapeutic treatment of myopia

TREATMENT FOR BK POLYOMAVIRUS INFECTION

ANTI-CD79B ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

Fusion protein bound to cell-permeable peptide, and composition comprising fusion protein or cell-permeable peptide and epithelial cell growth factor as active ingredients

Bi-specific fusion proteins

Modified EGF protein, production method therefor, and use thereof

EXTRACELLULAR VESICLES DERIVED FROM RECOMBINANT MICROORGANISM INCLUDING POLYNUCLEOTIDE ENCODING TARGET PROTEIN AND USE THEREOF

METHOD OF EFFECTING NEUROPROTECTION USING SOLUBLE NEUREGULIN ISOFORMS

GLA DOMAINS AS TARGETING AGENTS

EGFR BINDING MOIETY-PRESENTING BACTERIOPHAGES FOR TUMOUR TREATMENT

IN VIVO PRODUCTION OF PROTEINS

Method of effecting neuroprotection using soluble neuregulin isoforms

Treatment of infection by human enterovirus D68

Bi-specific fusion proteins

GLA DOMAINS AS THERAPEUTIC AGENTS

Synthetic proteins and therapeutic uses thereof

MULTIVALENT HETEROMULTIMER SCAFFOLD DESIGN AND CONSTRUCTS

EGF(A) ANALOGUES WITH FATTY ACID SUBSTITUENTS

DOMINANT NEGATIVE LIGAND CHIMERIC ANTIGEN RECEPTOR SYSTEMS

NOVEL CONJUGATES AND USES THEREOF

Self-assembling synthetic proteins

Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract

METHOD FOR EXTENDING HALF-LIFE OF PROTEIN

Bifunctional compounds

Fatty acid modified human epidermal growth factor

EGF(A) ANALOGUES, PREPARATION, FORMULATIONS AND USES THEREOF

COSMETIC COMPOSITION FOR IMPROVING SKIN CONDITIONS COMPRISING FUSION PROTEIN INCLUDING SKIN PENETRATION ENHANCING PEPTIDE

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

METHOD OF TREATING A BLADDER CANCER USING A CHIMERIC EGF-TARGETED BACTERIAL TOXIN

Combination grafts for tissue repair or regeneration applications

Ca2+ regulated binding agents

Bi-specific fusion proteins

TREATMENT FOR BK POLYOMAVIRUS INFECTION

TREATMENT OF INFECTION BY HUMAN ENTEROVIRUS D68

Three-dimensional micro-environment structure for controlling cell behavior, three-dimensional surface for controlling cell behavior, and method for manufacturing array and three-dimensional micro-environment structure

Multivalent heteromultimer scaffold design and constructs

Fusion polypeptides comprising one or more inclusion body tags, methods and uses

Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof

Tricalcium Phosphate Binding Peptides And Uses Thereof

In vivo production of proteins

CRYPTIC POLYPEPTIDES AND USES THEREOF

Method of effecting neuroprotection using soluble neuregulin isoforms

Delivery of therapeutic agents by a collagen binding protein

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS

Fusion protein, polynucleotide, genetic construct, producer, preparation for regeneration of cartilage

Fusion protein comprising antifreeze protein and human epidermal growth factor with increased anti-oxidant activity and skin cell proliferation effect and cosmetic composition for anti-wrinkle comprising the same as effective component

NOVEL EGFR VARIANT

Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2

SUPPRESSION OF CANCER

Multivalent heteromultimer scaffold design and constructs

GLA domains as therapeutic agents

Botulinum toxin-human epidermal growth factor fusion protein with increased skin cell proliferation and anti-oxidation effect and cosmetic composition for regenerating skin and improving skin wrinkle comprising the same as effective component

Agents for use in the therapeutic treatment of hyperopia

Skin probiotic formulation

Methods and compositions for producing epidermal growth factor (EGF) in soybeans

Anti-wrinkle and anti-aging cosmetic composition comprising green fluorescent protein-human epidermal growth factor fusion protein as effective component

EGF(A) analogues with fatty acid substituents

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES

Collagenase-derived peptides promote tissue regeneration and wound healing

Recombinant protein for preventing or treating tissue fibrosis and composition for preventing or treating tissue fibrosis comprising the same

Modified Polynucleotides for the production of biologics and proteins associated with human disease

Deimmunized therapeutic compositions and methods

Core constructs and their uses in configuring pharmaceutical molecules

Bi-specific fusion proteins

CRYPTIC POLYPEPTIDES AND USES THEREOF

Thermostable human epidermal growth factor-spider venom fusion protein with increased skin cell proliferation effect and cosmetic composition for anti-wrinkle and maintaining elasticity of skin comprising the same as effective component

Cryptic polypeptides and uses thereof

Recombinant proteins and their therapeutic uses

Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract

Controlled induction of human pancreatic progenitors produces functional beta-like cells

Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

In vivo production of proteins

Protein Comprising a Collagen Domain of CCBE1 and Uses Thereof

Bi-specific fusion proteins

Method of treating a bladder cancer using a chimeric EGF-targeted bacterial toxin

CHIMERIC ACTIVATORS: QUANTITATIVELY DESIGNED PROTEIN THERAPEUTICS AND USES THEREOF

Treatment of infection by human enterovirus D68

Method for preparing induced pluripotent stem cells using synthetic peptide

Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof

Delivery of therapeutic agents by a collagen binding protein

Multivalent heteromultimer scaffold design and constructs

COMPOSITIONS AND METHODS OF REGULATING BONE RESORPTION

TREATMENT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS

Dual targeting drug carrier and application thereof

Pharmaceuticals in joint-linker configurations for treating pathological blood clots

Method of effecting neuroprotection using soluble Neuregulin isoforms

Molecular constructs with targeting and effector moieties

Peptide core-based multi-arm linkers

Multivalent heteromultimer scaffold design and constructs

RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES

Molecular constructs for treating tumors

Human originated EGF domain proteins and use of the same

Method of treating myocardial infarction by administering a bi-specific fusion protein

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

Modified polynucleotides for the production of proteins

Dnazyme for silencing the expression of EGFR

Polynucleotide encoding a fusion protein for improving skin conditions

Treatment for BK polyomavirus infection

Gla domains as targeting agents

Epidermal growth factor fusion proteins with mutant cholera toxin B subunits

Modified polynucleotides for the production of biologics and proteins associated with human disease

Vault complexes

Means and method for expression of authentic human epidermal growth factor and/or basic fibrolast growth factor in cytoplasm and/or culture medium of

Fibulin protein variants and corresponding nucleic acid sequences

Gla domains as targeting agents

Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate

In vivo production of proteins

Composition for long-acting peptide analogs

Means and methods for modulating NOTCH3 protein expression and/or the coding region of NOTCH3; compositions and use thereof in the treatment of CADASIL

CHIMERIC TISSUE PLASMINOGEN ACTIVATOR (T-PA) RESIATANT TO PLASMINOGEN ACTIVATOR INHIBITOR-1 AND IMPROVED BIOCHEMICAL PROPERTIES

Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof

Modified polynucleotides for the production of cosmetic proteins and peptides

Methods and Uses for Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors

Cosmetic composition for improving skin conditions comprising fusion protein

EGFL7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis

Modified polynucleotides for the production of proteins

MODIFIED POLYNUCLEOTIDES ENCODING CASPASE 3

COMPOSITIONS AND METHODS FOR TREATMENT OF EXERCISE-INDUCED PULMONARY HEMORRHAGE OR NASOPHARYNGEAL CICATRIX

Highly stabilized epidermal growth factor mutants

Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract

Modified SAK gene for the production of recombinant proteins

Growth factor anchoring type bone graft material, method for producing growth factor anchoring type bone graft material, kit for producing growth factor anchoring type bone graft material, and method for forming bone

Activated collagen scaffold materials and their special fused active restoration factors

Activated collagen scaffold materials and their special fused active restoration factors

Suppression of cancer

Modified polynucleotides for treating protein deficiency

Recombinant proteins and their therapeutic uses

METHOD OF EFFECTING NEUROPROTECTION USING SOLUBLE NEUREGULIN ISOFORMS

Modified polynucleotides for treating galactosylceramidase protein deficiency

Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders

Modified polynucleotides encoding basic helix-loop-helix family member E41

Surface-active collagen membrane by peptide

Modified polynucleotides encoding citeD4

Bi-specific fusion proteins

Polypeptides

Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders

Modified polynucleotides encoding septin-4

Modified polynucleotides encoding granulysin

Modified polynucleotides encoding apoptosis inducing factor 1

Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy

Modified polynucleotides encoding hepatitis A virus cellular receptor 2

Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1

Modified polynucleotides encoding aquaporin-5

Methods and compositions for heptameric targeting ligands

Protein skeletal module which increases the binding affinity and binding specificity of active polypeptides

Tricalcium phosphate binding peptides and uses thereof

SELF COUPLING RECOMBINANT ANTIBODY FUSION PROTEINS

Method for producing human epidermal growth factor in large volume from yeast

Cartilage oligomeric matrix protein (COMP)—growth factor complexes and uses thereof

Anticancer fusion protein comprising trail and a growth factor receptor inhibitor

Selective anticancer chimeric peptides which bind neuropilin receptor

Selective anticancer chimeric peptides which bind transferrin receptor

Modified polynucleotides for the production of secreted proteins

Methods for cardioprotection and cardioregeneration with dimers of EGF family ligands

Modified SAK gene for the production of recombinant proteins

METHODS OF TREATING UROGENITAL-NEUROLOGICAL DISORDERS USING INTERLEUKIN RETARGETED ENDOPEPIDASES

Mutant epidermal growth factor polypeptides with improved biological activity and methods of their making and use

OPTICAL FLUORESCENT IMAGING IN HISTOLOGY

Method of selecting polypeptide sequence, and metal oxide or silicon-containing compound binding peptide and use thereof

Polypeptides

Peptides for active anti-cytokine immunization

COMPOSITIONS, METHODS, AND KITS FOR DETERMINING AN ALKYL TRANSFERASE

Optical fluorescent imaging

Multivalent heteromultimer scaffold design and constructs

Compositions and methods for treating bladder cancer

Method for producing proteins in that lack detectable cross binding activity to antibodies against host cell antigens

METHODS FOR PROTECTING DOPAMINERGIC NEURONS FROM STRESS AND PROMOTING PROLIFERATION AND DIFFERENTIATION OF OLIGODENDROCYTE PROGENITORS BY NRG-2

Stem cells, nucleotide sequences and proteins therefrom

Monocot seed product comprising a human blood protein

Vector for Expression of hEGF and Uses Thereof

Peptides for active anti-cytokine immunization

Compositions and methods for detecting EGFR in cancer

KNOCK-IN MICE WITH INDUCIBLE LOSS OF EOSINOPHILS

Target-specific non-antibody protein and method for preparing the same

Production of Biologically Active Proteins

Selective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide

Means and methods for modulating NOTCH3 protein expression and/or the coding region of NOTCH3; compositions and use thereof in the treatment of CADASIL

Bi-specific fusion proteins

Bi-specific fusion proteins for tissue repair

Chimeric activators: quantitatively designed protein therapeutics and uses thereof

PROTEOGLYCAN-BINDING PEPTIDES THAT MODULATE STEM CELL BEHAVIOR

SUPPRESSION OF CANCER

Human Notch3 based fusion proteins as decoy inhibitors of Notch3 signaling

Composition for long-acting peptide analogs

Vault complexes for facilitating biomolecule delivery

Non-cytotoxic fusion proteins comprising EGF muteins

Peptides for active anti-cytokine immunization

Methods, compounds, and compositions for treatment and prophylaxis in the respiratory tract

Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment and Diagnosis of Cancer

Prevention and treatment of inflammation and organ injury after ischemia/reperfusion using MFG-E8

Receptor-targeting reagents containing epidermal factor receptor-binding agents and IL-13 receptor-binding agents or IL-4 receptor-binding agents

Vector

Methods for inhibiting angiogenesis using EGFL8 antagonists

Methods of Treating Urogenital-Neurological Disorders Using Interleukin Retargeted Endopepidases

Purification and Use of a Factor for Supporting Wound Healing

ACTIVE SOLUBLE POST-TRANSLATIONALLY MODIFIED NEUREGULIN ISOFORMS

Hairless Transgenic Animal

NOVEL PROTEINS WITH TARGETED BINDING

Viral polyhedra complexes and methods of use

Protein scaffolds and uses thereof

Monocot seed product comprising a human serum albumin protein

SELF COUPLING RECOMBINANT ANTIBODY FUSION PROTEINS

Peptides for active anti-cytokine immunization

Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy

Peptides having activities of epidermal growth factor and its uses

EXPRESSION OF HUMAN MILK PROTEINS IN TRANSGENIC PLANTS

CLEAVAGE OF BIP BY SUBTILASE CYTOTOXIN

OPTICAL FLUORESCENT IMAGING

Protein having an EGF-like repeat sequence

Stable liquid compositions for treating stomatitis comprising epidermal growth factor

Human Blood Proteins Expressed in Monocot Seeds

PAN-HER ANTAGONISTS AND METHODS OF USE

Activated collagen scaffold materials and their special fused active restoration factors

CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS TO TUMOR CELLS OR TUMOR VASCULATURE AND PRODUCTION THEREOF

Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation

TARGETING TNF-alpha CONVERTING ENZYME(TACE)- DEPENDENT GROWTH FACTOR SHEDDING IN CANCER THERAPY

HUMAN BLOOD PROTEINS EXPRESSED IN MONOCOT SEEDS

Purification and use of a factor for supporting wound healing

MOLECULE AND CHIMERIC MOLECULES THEREOF

EGF-like nucleic acids and polypeptides and uses thereof

Extracellular/Epidermal Growth Factor Like Protein

MATRIX-TARGETED FUSION POLYPEPTIDES FOR TISSUE REGENERATION AND WOUND HEALING

Composition for long-acting peptide analogs

Stem cells, nucleotide sequences and proteins therefrom

USE OF CELL IMPLANTS IN BLADDER AND GUT OF NON-HUMAN ANIMALS FOR THE PRODUCTION OF PEPTIDES

Vector

Polypeptides

Expression of human milk proteins in transgenic plants

Method for Producing Epidermal Growth Factor Using Fusion Proteins Comprising Fas-1 Domain

Peptides for active anti-cytokine immunization

Mutant epidermal growth factor polypeptides, nucleic acids, and uses therefor

Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer

Method for the diagnosis and prognosis of demyelinating diseases

VECTOR SYSTEM

Expression of human milk proteins in transgenic plants

Methods of using novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants

Polynucleotides encoding anticoagulant fusion proteins

Production of biologically active proteins

Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof

AUGMENTATION OF WOUND HEALING BY eIF-4E mRNA AND EGF mRNA

Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same

Superantigen fusion protein for anti-cancer therapy and methods for the production thereof

Novel epidermal growth factor protein and gene, and methods of use therefor

Neuregulin protein regulation of synaptic proteins

EGR-EGFR complex

Vector

Optical fluorescent imaging

Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation

Peptides for active anti-cytokine immunization

Protein scaffolds and uses thereof

Peptabody for cancer treatment

Protein scaffolds and uses thereof

In vivo imaging of e2f-fegulated bioluminescent proteins

Method for preparing fusion polypeptide comprising epidermal growth factor and human serum albumin in plants

Novel preadipocyte factor-1-like polypeptides

Pan-HER antagonists and methods of use

Protein isolation and purification